DDInter854 DDInter1676
A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. nitrous oxide is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178)
Siponimod, also known as _Mayzent_, by Novartis, is a new drug formulated for the management of Multiple Sclerosis (MS). It was approved by the FDA on March 26, 2019 and by Health Canada on February 20, 2020. This drug is considered a _sphingosine-1-phosphate (S1P) receptor modulator_ and is thought to play a role in suppressing the central nervous system inflammation that is associated with MS [FDA label]. Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system that is chronic and inflammatory, disrupting communication between the brain and other parts of the body. Most patients diagnosed with this illness experience their initial disease symptoms between the age of 20 to 40, often the most productive years of life. Symptoms may include but are not limited to fatigue, gait changes, bowel or bladder dysfunction, abnormal muscle twitching, vision disturbance, and depressing or mood swings. MS is one of the most common causes of neurological disability in young adults and is found to occur more frequently in women than in men.[A176474,L5792]
Halothane {u} (Compound) resembles {v} (Compound) Isoflurane
Halothane {u} (Compound) binds {v} (Gene) GRIN2A
Halothane {u} may cause a minor interaction that can limit clinical effects when taken with {v} Prasugrel
Halothane {u} may cause a minor interaction that can limit clinical effects when taken with {v} Metronidazole
Halothane {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Sirolimus
Halothane {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Degarelix
Halothane {u} may lead to a major life threatening interaction when taken with {v} Cisapride
Halothane {u} may lead to a major life threatening interaction when taken with {v} Cabozantinib
Halothane (Compound) resembles Isoflurane (Compound)
Halothane (Compound) binds GRIN2A (Gene)
Halothane may cause a minor interaction that can limit clinical effects when taken with Prasugrel
Halothane may cause a minor interaction that can limit clinical effects when taken with Metronidazole
Halothane may cause a moderate interaction that could exacerbate diseases when taken with Sirolimus
Halothane may cause a moderate interaction that could exacerbate diseases when taken with Degarelix
Halothane may lead to a major life threatening interaction when taken with Cisapride
Halothane may lead to a major life threatening interaction when taken with Cabozantinib